Ken Griffin’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235K Buy
232,684
+179,276
+336% +$174K ﹤0.01% 11061
2025
Q4
$44.9K Sell
53,408
-67,933
-56% -$68K ﹤0.01% 12077
2025
Q3
$154K Buy
+121,341
New +$144K ﹤0.01% 11512
2025
Q1
Sell
-37,757
Closed -$48.7K 15415
2024
Q4
$48.7K Buy
+37,757
New +$43K ﹤0.01% 12419
2024
Q3
Sell
-26,195
Closed -$29.6K 15086
2024
Q2
$29.6K Buy
+26,195
New +$32.2K ﹤0.01% 12289
2021
Q4
Sell
-12,010
Closed -$73K 14608
2021
Q3
$73K Buy
+12,010
New +$100K ﹤0.01% 13130

Other funds holding RNXT

Ken Griffin's RNXT Position: Q1 2026 in Review

Ken Griffin increased its RenovoRx (RNXT) stake by 336% in Q1 2026, buying an estimated $174K and bringing the position to 232,684 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #11061.

Ken Griffin first reported a position in RNXT in Q3 2021 and has held it in 6 quarters since. 31 funds tracked by Wall St. Rank hold RNXT as of Q1 2026.

  • Ken Griffin held 232,684 shares of RenovoRx worth $235K as of Q1 2026.
  • Ken Griffin bought 179,276 RenovoRx shares in Q1 2026, an estimated $174K.
  • RenovoRx made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #11061 holding.
  • Ken Griffin first reported a position in RenovoRx in Q3 2021 and has held it in 6 quarters since.
  • 31 funds tracked by Wall St. Rank held RenovoRx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.